A new cancer drug has proven safe and effective for paediatric patients with a rare tumour gene mutation...
The post Larotrectinib shows promise in paediatric patients with TRK gene mutations appeared first on European Pharmaceutical Review.
Original Article: Larotrectinib shows promise in paediatric patients with TRK gene mutations